This news went out Friday afternoon on $ISOLF
ISODIOL INTERNATIONAL INC. SIGNS BINDING AGREEMENT TO ACQUIRE 100% OF C3 GLOBAL BIOSCIENCES
Isodiol International Inc. has entered into a binding agreement to acquire 100 per cent of C3 Global Biosciences (C3GBS), a cause-driven organization committed to developing sustainable health solutions through the advancement of cannabis science.
"Isodiol and C3GBS are truly complementary. We look forward to bringing the C3GBS brand and world-class team on board to pursue the shared vision of providing consumers with the highest quality of bioactive CBD [cannabidiol] products," said Marcos Agramont, chief executive officer of Isodiol. "By combining the two companies, we can align our efforts strategically to further strengthen our portfolio of assets. This partnership will be aimed at increasing market expertise as we establish both companies as leaders in the CBD market."
C3GBS's mission is to be the global leader in CBD research, science, innovation and technology to impact consumer lives resulting in markedly improved patient outcomes through sound clinical studies and evidence-based empirical data gathered by validated devices and platforms. It is passionately driven to continue the research and development of CBD and other cannabinoids to improve the quality of life for athletes on and off the field.
C3GBS is proud to partner with and support the mission of Athletes for Care and play a key role in creating a community where athletes can find support, opportunity and purpose in life after a career in sports.
Dr. H.J. Raza, chief medical officer for C3GBS, will join the team as a member of Isodiol's medical advisory board, where he will provide insight, scientific direction and expertise to the company. Dr. Raza, an internationally respected physician, researcher and educator, brings with him more than 25 years of professional experience. Dr. Raza completed his medical education (MD) and neuroscience research (PhD) at the Mount Sinai School of Medicine, with training and board certification in internal medicine at the NYU Medical Center.
